Eintrag weiter verarbeiten

Minimal residual disease-directed therapy in acute myeloid leukemia

Gespeichert in:

Veröffentlicht in: Blood 125(2015), 15, Seite 2331-2335
Personen und Körperschaften: Kayser, Sabine (VerfasserIn)
Titel: Minimal residual disease-directed therapy in acute myeloid leukemia/ Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter
Format: E-Book-Kapitel
Sprache: Englisch
veröffentlicht:
28 January 2015
Gesamtaufnahme: : Blood, 125(2015), 15, Seite 2331-2335
, volume:125
Quelle: Verbunddaten SWB
Lizenzfreie Online-Ressourcen
LEADER 02111caa a2200457 4500
001 0-1560731508
003 DE-627
005 20220813193240.0
007 cr uuu---uuuuu
008 170711s2015 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2014-11-578815  |2 doi 
035 |a (DE-627)1560731508 
035 |a (DE-576)490731503 
035 |a (DE-599)BSZ490731503 
035 |a (OCoLC)1340977081 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
100 1 |a Kayser, Sabine  |d 1979-  |e VerfasserIn  |0 (DE-588)138694923  |0 (DE-627)605256233  |0 (DE-576)30778813X  |4 aut 
245 1 0 |a Minimal residual disease-directed therapy in acute myeloid leukemia  |c Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter 
264 1 |c 28 January 2015 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.07.2017 
520 |a Case 1: A 35-year-old man with a normal white blood cell (WBC) count (9.3 × 10 9 /L) was diagnosed with acute myeloid leukemia (AML) with a t(8;21)(q22;q22) translocation in 25/25 metaphases. The RUNX1-RUNX1T1 fusion gene was detected by real-time quantitative polymerase chain reaction (PCR), 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 125(2015), 15, Seite 2331-2335  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnns 
773 1 8 |g volume:125  |g year:2015  |g number:15  |g pages:2331-2335  |g extent:5 
856 4 0 |u http://dx.doi.org/10.1182/blood-2014-11-578815  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.bloodjournal.org/content/125/15/2331  |x Verlag  |z kostenfrei  |3 Volltext 
936 u w |d 125  |j 2015  |e 15  |h 2331-2335  |g 5 
951 |a AR 
856 4 0 |u http://dx.doi.org/10.1182/blood-2014-11-578815  |9 LFER 
852 |a LFER  |z 2017-08-09T00:00:00Z 
970 |c OD 
971 |c EBOOK 
972 |c EBOOK 
973 |c Aufsatz 
935 |a lfer 
951 |b ZZ 
980 |a 1560731508  |b 0  |k 1560731508  |o 490731503  |c lfer 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Minimal+residual+disease-directed+therapy+in+acute+myeloid+leukemia&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Kayser%2C+Sabine&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1528-0020
SOLR
_version_ 1757948516237312000
access_facet Electronic Resources
author Kayser, Sabine
author_facet Kayser, Sabine
author_role aut
author_sort Kayser, Sabine 1979-
author_variant s k sk
callnumber-sort
collection lfer
container_reference 125(2015), 15, Seite 2331-2335
container_title Blood
contents Case 1: A 35-year-old man with a normal white blood cell (WBC) count (9.3 × 10 9 /L) was diagnosed with acute myeloid leukemia (AML) with a t(8;21)(q22;q22) translocation in 25/25 metaphases. The RUNX1-RUNX1T1 fusion gene was detected by real-time quantitative polymerase chain reaction (PCR),
ctrlnum (DE-627)1560731508, (DE-576)490731503, (DE-599)BSZ490731503, (OCoLC)1340977081
doi_str_mv 10.1182/blood-2014-11-578815
facet_avail Online, Free
finc_class_facet not assigned
finc_id_str 0019177394
footnote Gesehen am 11.07.2017
format ElectronicBookComponentPart
format_access_txtF_mv Article, E-Article
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-monograph-child
format_dezi4 e-Book
format_finc Article, E-Article
format_legacy ElectronicBookPart
format_strict_txtF_mv E-Article
geogr_code not assigned
geogr_code_person Other places
hierarchy_parent_id 0-266886647
hierarchy_parent_title Blood
hierarchy_sequence 125(2015), 15, Seite 2331-2335
hierarchy_top_id 0-266886647
hierarchy_top_title Blood
id 0-1560731508
illustrated Not Illustrated
imprint 28 January 2015
imprint_str_mv 28 January 2015
institution DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2
is_hierarchy_id 0-1560731508
is_hierarchy_title Minimal residual disease-directed therapy in acute myeloid leukemia
isil_str_mv LFER
issn 1528-0020
kxp_id_str 1560731508
language English
last_indexed 2023-02-16T01:19:08.111Z
marc024a_ct_mv 10.1182/blood-2014-11-578815
match_str kayser2015minimalresidualdiseasedirectedtherapyinacutemyeloidleukemia
mega_collection Verbunddaten SWB, Lizenzfreie Online-Ressourcen
misc_de105 EBOOK
multipart_link 075961938
multipart_part (075961938)125(2015), 15, Seite 2331-2335
names_id_str_mv (DE-588)138694923, (DE-627)605256233, (DE-576)30778813X
oclc_num 1340977081
physical 5
publishDate 28 January 2015
publishDateSort 2015
publishPlace
publisher
record_format marcfinc
record_id 490731503
recordtype marcfinc
rvk_facet No subject assigned
source_id 0
spelling Kayser, Sabine 1979- VerfasserIn (DE-588)138694923 (DE-627)605256233 (DE-576)30778813X aut, Minimal residual disease-directed therapy in acute myeloid leukemia Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter, 28 January 2015, 5, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 11.07.2017, Case 1: A 35-year-old man with a normal white blood cell (WBC) count (9.3 × 10 9 /L) was diagnosed with acute myeloid leukemia (AML) with a t(8;21)(q22;q22) translocation in 25/25 metaphases. The RUNX1-RUNX1T1 fusion gene was detected by real-time quantitative polymerase chain reaction (PCR),, Enthalten in Blood Washington, DC : American Society of Hematology, 1946 125(2015), 15, Seite 2331-2335 Online-Ressource (DE-627)266886647 (DE-600)1468538-3 (DE-576)075961938 1528-0020 nnns, volume:125 year:2015 number:15 pages:2331-2335 extent:5, http://dx.doi.org/10.1182/blood-2014-11-578815 Verlag Resolving-System kostenfrei Volltext, http://www.bloodjournal.org/content/125/15/2331 Verlag kostenfrei Volltext, http://dx.doi.org/10.1182/blood-2014-11-578815 LFER, LFER 2017-08-09T00:00:00Z
spellingShingle Kayser, Sabine, Minimal residual disease-directed therapy in acute myeloid leukemia, Case 1: A 35-year-old man with a normal white blood cell (WBC) count (9.3 × 10 9 /L) was diagnosed with acute myeloid leukemia (AML) with a t(8;21)(q22;q22) translocation in 25/25 metaphases. The RUNX1-RUNX1T1 fusion gene was detected by real-time quantitative polymerase chain reaction (PCR),
swb_id_str 490731503
title Minimal residual disease-directed therapy in acute myeloid leukemia
title_auth Minimal residual disease-directed therapy in acute myeloid leukemia
title_full Minimal residual disease-directed therapy in acute myeloid leukemia Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter
title_fullStr Minimal residual disease-directed therapy in acute myeloid leukemia Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter
title_full_unstemmed Minimal residual disease-directed therapy in acute myeloid leukemia Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter
title_in_hierarchy Minimal residual disease-directed therapy in acute myeloid leukemia / Sabine Kayser, Richard F. Schlenk, David Grimwade, Victor E. D. Yosuico, and Roland B. Walter,
title_short Minimal residual disease-directed therapy in acute myeloid leukemia
title_sort minimal residual disease directed therapy in acute myeloid leukemia
url http://dx.doi.org/10.1182/blood-2014-11-578815, http://www.bloodjournal.org/content/125/15/2331